Intelligent Bio Solutions Inc. (INBS) - Total Assets
Based on the latest financial reports, Intelligent Bio Solutions Inc. (INBS) holds total assets worth $10.04 Million USD as of September 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
Intelligent Bio Solutions Inc. - Total Assets Trend (2017–2025)
This chart illustrates how Intelligent Bio Solutions Inc.'s total assets have evolved over time, based on quarterly financial data. Also see INBS market cap for the company's overall valuation and market capitalisation.
Intelligent Bio Solutions Inc. - Asset Composition Analysis
Current Asset Composition (June 2025)
Intelligent Bio Solutions Inc.'s total assets of $10.04 Million consist of 50.2% current assets and 49.8% non-current assets. Review Intelligent Bio Solutions Inc. balance sheet liabilities to assess the company's total debt and financial obligations.
| Asset Category | Amount (USD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 12.4% |
| Accounts Receivable | $1.60 Million | 19.4% |
| Inventory | $635.22K | 7.7% |
| Property, Plant & Equipment | $0.00 | 0.0% |
| Intangible Assets | $3.79 Million | 45.9% |
| Goodwill | $0.00 | 0.0% |
Asset Composition Trend (2017–2025)
This chart illustrates how Intelligent Bio Solutions Inc.'s asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. See Intelligent Bio Solutions Inc. (INBS) share price today for real-time trading data and today's change.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Intelligent Bio Solutions Inc.'s current assets represent 50.2% of total assets in 2025, a decrease from 100.0% in 2017.
- Cash Position: Cash and equivalents constituted 12.4% of total assets in 2025, up from 8.4% in 2017.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 45.0% of total assets, an increase from 0.0% in 2017.
- Asset Diversification: The largest asset category is intangible assets at 45.9% of total assets.
Intelligent Bio Solutions Inc. Competitors by Total Assets
Key competitors of Intelligent Bio Solutions Inc. based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Medtronic plc
SA:MDTC34
|
Brazil | R$93.03 Billion |
|
Demant A/S
CO:DEMANT
|
Denmark | Dkr39.07 Billion |
|
Jiangsu Yuyue Medical Equipment & Supply Co Ltd
SHE:002223
|
China | CN¥16.89 Billion |
|
Jafron Biomedical Co Ltd
SHE:300529
|
China | CN¥5.20 Billion |
|
Sinocare Inc
SHE:300298
|
China | CN¥6.25 Billion |
|
Emvision Medical Devices Ltd
AU:EMV
|
Australia | AU$24.94 Million |
|
Theradiag SA
PA:ALTHE
|
France | €11.55 Million |
|
Biosynex
PA:ALBIO
|
France | €149.44 Million |
Intelligent Bio Solutions Inc. - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 0.89 | 1.57 | 17.12 |
| Quick Ratio | 0.76 | 1.42 | 17.12 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | $-577.71K | $3.08 Million | $18.80 Million |
Intelligent Bio Solutions Inc. - Advanced Valuation Insights
This section examines the relationship between Intelligent Bio Solutions Inc.'s asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 2.18 |
| Latest Market Cap to Assets Ratio | 0.79 |
| Asset Growth Rate (YoY) | -40.1% |
| Total Assets | $8.25 Million |
| Market Capitalization | $6.50 Million USD |
Valuation Analysis
Below Book Valuation: The market values Intelligent Bio Solutions Inc.'s assets below their book value (0.79x), which may indicate investor concerns about asset quality or future growth.
Significant Asset Reduction: Intelligent Bio Solutions Inc.'s assets decreased by 40.1% over the past year, potentially indicating divestiture, restructuring, or challenging business conditions.
Annual Total Assets for Intelligent Bio Solutions Inc. (2017–2025)
The table below shows the annual total assets of Intelligent Bio Solutions Inc. from 2017 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-06-30 | $8.25 Million | -40.13% |
| 2024-06-30 | $13.78 Million | +33.07% |
| 2023-06-30 | $10.35 Million | -16.17% |
| 2022-06-30 | $12.35 Million | -43.49% |
| 2021-06-30 | $21.86 Million | +782.98% |
| 2020-06-30 | $2.48 Million | +6.34% |
| 2019-06-30 | $2.33 Million | -6.73% |
| 2018-06-30 | $2.50 Million | +274.07% |
| 2017-06-30 | $667.23K | -- |
About Intelligent Bio Solutions Inc.
Intelligent Bio Solutions Inc., a medical technology company, focused on developing and delivering non-invasive testing, and screening solutions in Asia Pacific, the United States, the United Kingdom, and internationally. The company operates intelligent fingerprinting drug screening system, a platform to analyze fingerprint sweat analysis to detect drugs abuse; and biosensor platform. The compan… Read more